[1] Doerks T, Copley RR, Schultz J, et al. Systematic identification of novel protein domain families associated with nuclear functions. Genome Res. 2002;12(1):47-56.[2] Cannonier SA, Sterling JA. The Role of Hedgehog Signaling in Tumor Induced Bone Disease. Cancers (Basel). 2015;7(3): 1658-1683.[3] McMahon AP, Ingham PW, Tabin CJ, et al. Developmental roles and clinical significance of Hedgehog signaling. Curr Top Dev Biol. 2003;53:1-114.[4] Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature. 1996;383(6599):407-413.[5] Bitgood MJ, Shen L, McMahon AP, et al. Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr Biol. 1996;6(3):298-304.[6] Mirsky R, Parmantier E, McMahon AP, et al. Schwann Cell‐Derived Desert Hedgehog Signals Nerve Sheath Formation. Ann New York Acad Sci. 1999;883(1):196-202.[7] Marigo V, Davey RA, Zuo Y, et al. Biochemical evidence that patched is the Hedgehog receptor. Nature. 1996; 384(6605): 176-179.[8] Murone M, Rosenthal A, de Sauvage FJ, et al. Sonic hedgehog signaling by the patched–smoothened receptor complex. Curr Biol. 1999;9(2):76-84.[9] Jemtland R, Divieti P, Lee K, et al. Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion. Bone. 2003; 32(6):611-620.[10] Zhang XM, Ramalho-Santos M, McMahon AP, et al. Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R symmetry by the mouse node. Cell. 2001;106(2):781-792.[11] McMahon AP. More surprises in the Hedgehog signaling pathway. Cell. 2000;100(2):185-188.[12] Amano K, Densmore MJ, Lanske B, et al. Conditional Deletion of Indian Hedgehog in Limb Mesenchyme Results in Complete Loss of Growth Plate Formation but Allows Mature Osteoblast Differentiation. J Bone Miner Res. 2015;30(12): 2262-2272.[13] Tian Y, Xu Y, Fu Q, et al. Osterix is required for Sonic hedgehog-induced osteoblastic MC3T3-E1 cell differentiation. Cell Biochem Biophys. 2012;64(3):169-176.[14] Nakamura T, Naruse M, Chiba Y, et al. Novel hedgehog agonists promote osteoblast differentiation in mesenchymal stem cells. J Cell Physiol. 2015. 230(4):922-929.[15] Shimoyama A, Wada M, Ikeda F, et al. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell. 2007;18(7): 2411-2418.[16] Tu X, Joeng KS, Long F, et al. Indian hedgehog requires additional effectors besides Runx2 to induce osteoblast differentiation. Dev Biol. 2012;362(1):76-82.[17] Ohba S, Kawaguchi H, Kugimiya F, et al. Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity. Dev Cell. 2008;14(5): 689-699.[18] Ben-awadh AN, Delgado-Calle J, Tu X, et al. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. Endocrinology. 2014;155(8):2797-2809.[19] Mak KK, Bi Y, Wan C, et al. Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression. Dev Cell. 2008; 14(5):674-688.[20] Huang JC, Sakata T, Pfleger LL, et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004;19(2):235-244.[21] Boabaid F, Berry JE, Koh AJ, et al. The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. J Periodontol. 2004; 75(9):1247-1254.[22] Kim S, Yamazaki M, Shevde NK, et al. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol Endocrinol. 2007; 21(1):197-214.[23] Fu Q, Manolagas SC, and O'Brien CA, et al. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol. 2006;26(17):6453-6468.[24] Fu Q, Jilka RL, Manolagas SC, et al. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem. 2002; 277(50):48868-48875.[25] Zhuang LL, Jin R, Zhu LH, et al. Promoter characterization and role of cAMP/PKA/CREB in the basal transcription of the mouse ORMDL3 gene. PLoS One. 2013;8(4):e60630.[26] Sands WA, Palmer TM. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal. 2008;20(3): 460-466.[27] Bidwell P, Joh K, Leaver HA, et al. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK. Prostaglandins Other Lipid Mediat. 2010;91(1-2):18-29.[28] Park HJ, Baek K, Baek JH, et al. The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells. J Cell Physiol. 2015;230(3): 667-679.[29] Lee HL, Bae OY, Baek KH, et al. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-kappaB ligand in osteoblasts. Bone. 2011;49(2): 242-249.[30] Takami M, Takahashi N, Udagawa N, et al. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Endocrinology. 2000;141(12):4711-4719.[31] Datta NS, Abou-Samra AB. PTH and PTHrP signaling in osteoblasts. Cell Signal. 2009;21(8):1245-1254.[32] Akhtari M, Mansuri J, Newman KA, et al. Biology of breast cancer bone metastasis. Cancer Biol Ther. 2008;7(1):3-9.[33] Hirai T, Kobayashi T, Nishimori S, et al. Bone Is a Major Target of PTH/PTHrP Receptor Signaling in Regulation of Fetal Blood Calcium Homeostasis. Endocrinology. 2015; 156(8):2774-2780.[34] Zayzafoon M. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem. 2006;97(1):56-70.[35] Shin J, Jang H, Lin J, et al. PKCbeta positively regulates RANKL-induced osteoclastogenesis by inactivating GSK-3beta. Mol Cells. 2014;37(10):747-752.[36] Yao J, Li J, Zhou L, et al. Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-kappaB and NFAT activity. J Cell Physiol. 2015;230(6):1235-1242.[37] Malaval L, Prideaux M, Dallas SL, et al. Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms. Plos One. 2015;10(5):e0125731. |